Physicians' Academy for Cardiovascular Education

Potassium binding in heart failure management - Enabling guideline-recommended RAASi therapy

Meeting report with presentation slides, videos and online CME of a PACE-CME symposium held during ESC 2021, The Digital Experience.

The clinical dilemma of RAASi therapy and hyperkalemia

10' education - Oct. 20, 2021 - Prof. Javed Butler, MD - Online CME
What to do when abnormalities of potassium occur in HF patients? Prof. Butler discusses the recommendations in guidelines and a recent practical guidance paper in JACC.

What to do when abnormalities of potassium occur in HF patients? Prof. Butler discusses the recommendations in guidelines and a recent practical guidance paper in JACC.

Discussion: Potassium binding in heart failure management - Enabling guideline-recommended RAASi therapy

Oct. 19, 2021

Watch the discussion by the expert faculty of the symposium with prof. Stefan Anker, prof. Andrew Coats and prof. Javed Butler.

E-learning Potassium binding in heart failure management

Accredited E-Learning

Online-CME - This course consists of 3 parts.
This course consists of 3 parts.

In this series, three experts in heart failure discuss the dilemma of discontinuation/reducing RAASi and lose the benefits of RAASi vs. continued RAASi and accept the presence of hyperkalemia. Moreover, the option of novel potassium binders is presented, when and how to use these agents?

RAASi as a fundamental pillar in HF

10' education - Oct. 4, 2021 - Prof. Andrew Coats, MD - Online CME
Prof. Coats states that RAASi is the mainstay of HFrEF therapy, but that elevated potassium levels in HF patients may be perceived as a barrier for optimal RAASi dosing.

Prof. Coats states that RAASi is the mainstay of HFrEF therapy, but that elevated potassium levels in HF patients may be perceived as a barrier for optimal RAASi dosing.

Risks associated with hyperkalemia

10' education - Sep. 16, 2021 - Prof. Stefan Anker, MD, PhD - Online CME
Hyperkalemia is a major clinical problem. Prof. Stefan Anker talks about problems and risk associated with hyperkalemia.

Hyperkalemia is a major clinical problem. Prof. Stefan Anker talks about problems and risk associated with hyperkalemia.

Slides: RAASi as a fundamental pillar in heart failure: The challenges to optimize management

Slides (presentation) - Sep. 13, 2021 - Prof. Andrew Coats, MD - Coventry, UK - CME symposium held during ESC Congress 2021
This lecture by Prof. Andrew Coats was part of a EBAC-accredited symposium

Slides as educational service to PACE members and meeting participants.

Slides: Abnormal potassium levels as clinical problem why monitor patients for hyperkalemia?

Slides (presentation) - Sep. 13, 2021 - Prof. Stefan Anker, MD, PhD - Berlin, Germany - CME symposium held during ESC Congress 2021
This lecture by Prof. Stefan Anker was part of a EBAC-accredited symposium

Slides as educational service to PACE members and meeting participants.

Slides: The clinical dilemma of RAASi & hyperkalemia - When and how to introduce potassium binding?

Slides (presentation) - Sep. 13, 2021 - Prof. Javed Butler, MD - Jackson, MS, USA - CME symposium held during ESC Congress 2021
This lecture by Prof. Javed Butler was part of a EBAC-accredited symposium

Slides as educational service to PACE members and meeting participants.

Potassium binding in heart failure management - Enabling guideline-recommended RAASi therapy